Literature DB >> 17964021

Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.

Christopher J Farrell1, Scott R Plotkin.   

Abstract

Several familial syndromes are associated with an increased incidence of nervous system tumors. Recognition of these syndromes is critical to provide optimal clinical care and genetic counseling to affected patients and their families. Identification of the genetic defects responsible for these relatively uncommon disorders has led to the improved understanding of critical molecular pathways involved in tumorigenesis and has contributed to the emergence of molecularly targeted therapeutics against cancer. The hereditary syndromes and diseases included in this review are limited to those associated with brain tumors: neurofibromatosis 1, neurofibromatosis 2, tuberous sclerosis complex, von Hippel-Lindau disease, and the less frequently encountered Cowden disease and Li-Fraumeni, Turcot's, and Gorlin's syndromes.

Entities:  

Mesh:

Year:  2007        PMID: 17964021     DOI: 10.1016/j.ncl.2007.07.008

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  31 in total

1.  Older age at the completion of linear growth is associated with an increased risk of adult glioma.

Authors:  Rebecca B Little; L Burt Nabors; Jeffrey J Olson; Zachary J Thompson; Carrie M Rozmeski; Renato V LaRocca; Peter A Forsyth; Reid C Thompson; Robert A Oster; Sajeel A Chowdhary; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2017-03-04       Impact factor: 2.506

2.  The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

Authors:  Adelheid Wöhrer; Thomas Waldhör; Harald Heinzl; Monika Hackl; Johann Feichtinger; Ulrike Gruber-Mösenbacher; Andreas Kiefer; Hans Maier; Reinhard Motz; Angelika Reiner-Concin; Bernd Richling; Carmen Idriceanu; Michael Scarpatetti; Roland Sedivy; Hans-Christian Bankl; Wolfgang Stiglbauer; Matthias Preusser; Karl Rössler; Johannes Andreas Hainfellner
Journal:  J Neurooncol       Date:  2009-06-28       Impact factor: 4.130

3.  Brain tumor risk according to germ-line variation in the MLLT10 locus.

Authors:  Kathleen M Egan; Rebekah Baskin; L Burton Nabors; Reid C Thompson; Jeffrey J Olson; James E Browning; Melissa H Madden; Alvaro N Monteiro
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

4.  Rare and uncommon genetic variants may hold key to the 'missing heritability' in glioma.

Authors:  Kathleen M Egan; Margaret R Wrensch; Robert B Jenkins
Journal:  CNS Oncol       Date:  2012-11

5.  Prion Protein Expression is Correlated with Glioma Grades.

Authors:  Qiaoli Luo; Yisong Wang; Dongying Fan; Shijie Wang; Peigang Wang; Jing An
Journal:  Virol Sin       Date:  2020-03-31       Impact factor: 4.327

6.  Absence of human cytomegalovirus infection in childhood brain tumors.

Authors:  Iacopo Sardi; Maurizio Lucchesi; Sabrina Becciani; Ludovica Facchini; Milena Guidi; Anna Maria Buccoliero; Maria Moriondo; Gianna Baroni; Alessia Stival; Silvia Farina; Lorenzo Genitori; Maurizio de Martino
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

7.  Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.

Authors:  Dayane B Koshiyama; Patrícia Trevisan; Carla Graziadio; Rafael F M Rosa; Bibiana Cunegatto; Juliete Scholl; Valentina O Provenzi; Alexandre P de Sá; Fabiano P Soares; Maíra C Velho; Nelson de A P Filho; Ceres A Oliveira; Paulo R G Zen
Journal:  J Neurooncol       Date:  2017-08-30       Impact factor: 4.130

8.  Neurofibromatosis type 1 and high-grade tumors of the central nervous system.

Authors:  Amy Rosenfeld; Robert Listernick; Joel Charrow; Stewart Goldman
Journal:  Childs Nerv Syst       Date:  2009-11-25       Impact factor: 1.475

9.  Genome-wide association study of glioma and meta-analysis.

Authors:  Preetha Rajaraman; Beatrice S Melin; Zhaoming Wang; Roberta McKean-Cowdin; Dominique S Michaud; Sophia S Wang; Melissa Bondy; Richard Houlston; Robert B Jenkins; Margaret Wrensch; Meredith Yeager; Anders Ahlbom; Demetrius Albanes; Ulrika Andersson; Laura E Beane Freeman; Julie E Buring; Mary Ann Butler; Melissa Braganza; Tania Carreon; Maria Feychting; Sarah J Fleming; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Goran Hallmans; Roger Henriksson; Judith Hoffman-Bolton; Peter D Inskip; Christoffer Johansen; Cari M Kitahara; Mark Lathrop; Chenwei Liu; Loic Le Marchand; Martha S Linet; Stefan Lonn; Ulrike Peters; Mark P Purdue; Nathaniel Rothman; Avima M Ruder; Marc Sanson; Howard D Sesso; Gianluca Severi; Xiao-Ou Shu; Matthias Simon; Meir Stampfer; Victoria L Stevens; Kala Visvanathan; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Paul Decker; Victor Enciso-Mora; Brooke Fridley; Yu-Tang Gao; Matthew Kosel; Daniel H Lachance; Ching Lau; Terri Rice; Anthony Swerdlow; Joseph L Wiemels; John K Wiencke; Sanjay Shete; Yong-Bing Xiang; Yuanyuan Xiao; Robert N Hoover; Joseph F Fraumeni; Nilanjan Chatterjee; Patricia Hartge; Stephen J Chanock
Journal:  Hum Genet       Date:  2012-08-11       Impact factor: 4.132

Review 10.  Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Authors:  April D Sorrell; Carin R Espenschied; Julie O Culver; Jeffrey N Weitzel
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.